Photo of Yvette D. Clarke
D United States House · District 9 · New York On the 2026 ballot

Rep. Yvette D. Clarke

Compare
Total votes
2,837
all sessions
Attendance
99%
40 missed
Near the chamber average
With party
97%
of cast votes
Near the chamber average
Bipartisan score
2%
crosses aisle rarely
Near the chamber average
Sponsored
2,018
bills & resolutions
Higher than 91% of chamber peers
Committees
4
assignments
2,018 bills and resolutions

Sponsored bills

Total
2,018
Primary
83
Co-sponsor
1,935
This page
2,018
matching current filters
Co-sponsor HR 6349
In committee · United States House · Co-sponsor
Migrant Due Process Protection Act

Maddy summaryThe Migrant Due Process Protection Act (HR 6349) would require immigration judges to allow non-citizens in removal proceedings (who are not held in government custody) to request virtual hearings via video or phone. Judges must approve such requests and ensure virtual formats do not disadvantage the individual. This directly affects people facing deportation who are not currently detained by immigration authorities. The bill adds a new procedural option for remote hearings without changing legal standards or outcomes.

In committee Dec 2, 2025 1 co-sponsor
Primary HR 6356
In committee · United States House · Lead sponsor
Artificial Intelligence Civil Rights Act of 2025

Maddy summaryThe Artificial Intelligence Civil Rights Act of 2025 requires developers and deployers of AI systems that make decisions affecting "consequential actions" (such as employment, housing, healthcare, education, and credit) to conduct pre-deployment evaluations and annual impact assessments by independent auditors. The bill mandates transparency requirements including clear disclosures to individuals about how AI is used in decision-making, establishes a right to human alternatives for significant AI-driven decisions, and prohibits discrimination based on protected characteristics like race, gender, or disability. It creates enforcement mechanisms through the Federal Trade Commission, state attorneys general, and private lawsuits, with penalties including civil penalties of up to 4% of annual revenue. The act also requires developers to provide explanations for AI-driven decisions and sets standards for data collection to prevent harm and ensure fairness in critical life areas.

In committee Dec 2, 2025 0 co-sponsors
Co-sponsor HR 1262
Passed · United States House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 6090
In committee · United States House · Co-sponsor
FRESHER Act of 2025

Maddy summaryThe FRESHER Act of 2025 requires the Secretary of the Interior to study stormwater runoff impacts from oil, gas, and mining operations on groundwater and aquifers. It mandates a specific analysis of measurable contamination, groundwater resources, and aquifer susceptibility to contamination in affected areas. The study must be completed within one year of the bill's enactment, with results reported to Congress. This bill directly affects oil, gas, and mining operations by establishing new federal study requirements for their stormwater runoff.

In committee Nov 29, 2025 1 co-sponsor
Co-sponsor HRES 909
In committee · United States House · Co-sponsor
Recognizing that immigrant justice and reproductive justice are inseparable and must be pursued together.

Maddy summaryHRES 909 is a House resolution affirming that immigrant justice and reproductive justice are interconnected and must be addressed together. It calls on the Department of Homeland Security to reinstate protections for pregnant individuals in detention, eliminate the 5-year bar restricting immigrants’ access to federal health programs like Medicaid, and implement transparent oversight of reproductive health care in detention facilities. The resolution also urges Congress to remove barriers to health care access for immigrants and requires federal agencies to report on policies affecting reproductive health care for detained individuals. This resolution directly affects policies toward immigrants in detention, particularly regarding access to abortion, prenatal care, and mental health services, but does not create new laws.

In committee Nov 21, 2025 1 co-sponsor
Co-sponsor HR 6214
In committee · United States House · Co-sponsor
Kidney Care Access Protection Act

Maddy summaryThe Kidney Care Access Protection Act (HR 6214) improves access to innovative kidney treatments for Medicare beneficiaries with end-stage renal disease. It extends transitional payment adjustments for new renal dialysis drugs and devices for at least three years, then establishes permanent payment adjustments based on actual utilization and costs. The bill also expands Medicare's annual wellness benefit to include kidney disease screening and increases access to kidney disease education services through renal dialysis facilities. These changes apply to Medicare beneficiaries, renal dialysis facilities, and healthcare providers, with key provisions effective January 1, 2026.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6241
In committee · United States House · Co-sponsor
Urban and Rural Diabetes Initiative Act

Maddy summaryThis bill establishes a federal grant program to improve diabetes care in underserved urban and rural communities. It authorizes the Health Secretary to fund eligible providers - including community health centers, rural clinics, and tribal health departments - to deliver comprehensive services like routine diabetes treatment, prevention education, eye/foot care, and kidney disease management. Grants require providers to offer culturally appropriate care in local languages and conduct community outreach. Funding must be distributed equitably between urban and rural areas, with authorization for fiscal years 2026-2031. The program directly supports patients in medically underserved communities facing barriers to diabetes care.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6242
In committee · United States House · Co-sponsor
Healthy MOM Act

Maddy summaryThe Healthy MOM Act (HR 6242) would require health insurance plans to provide a special enrollment period for pregnant individuals beginning when pregnancy is reported to the insurer. It mandates that group health plans and health insurance issuers cover maternity care, including childbirth and postpartum care, for all dependents regardless of age. The bill would extend Medicaid coverage for pregnant individuals and infants to 12 months postpartum (instead of ending at 60 days postpartum) and make this 12-month coverage permanent. These provisions would directly affect pregnant individuals, women with dependent children who are pregnant, and health insurance plans and Medicaid programs.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6166
In committee · United States House · Co-sponsor
Lowering Drug Costs for American Families Act

Maddy summaryThis bill expands Medicare's drug price negotiation program to cover 50 drugs (up from 20) and requires health insurers to apply negotiated prices to cost-sharing for beneficiaries. It establishes annual out-of-pocket cost-sharing limits for prescription drugs under group health plans and insurance coverage, with specific limits of $2,000 for self-only coverage in 2027 that will increase annually. The bill also sets specific cost-sharing limits for insulin products, requiring coverage with no deductible and cost-sharing of no more than $35 per 30-day supply or 25% of the negotiated price. These provisions affect Medicare beneficiaries, people with group health plans, and health insurers across the country. The bill applies to plan years beginning on or after January 1, 2027.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6212
In committee · United States House · Co-sponsor
Good Samaritan Menstrual Products Act

Maddy summaryHR 6212, the Good Samaritan Menstrual Products Act, protects donors and nonprofits from liability when providing menstrual products in good faith. It shields people, manufacturers, distributors, and nonprofits from civil or criminal liability for the condition of "apparently usable" donated products (those meeting all safety standards but not necessarily marketable). The law applies to products like tampons, cups, and liners distributed to individuals in need through nonprofits. Liability protection does not apply if gross negligence or intentional misconduct causes injury or death.

In committee Nov 20, 2025 1 co-sponsor
Showing 241 to 250 of 2,018 bills
Previous 1 … 24 25 26 … 202 Next